Alibaba Health Information Technology (FRA:TWYA) Beneish M-Score: -1.95 (As of Jun. 25, 2026)


FRA:TWYA Alibaba Health Information Technology Ltd FRA:TWYA
83 GF Score
Price €5.90
GF Value €9.91
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Beneish M-Score?

Alibaba Health Information Technology FRA:TWYA -3.28% 83 Beneish M-Score is -1.95 as of Jun. 25, 2026. GuruFocus rates FRA:TWYA with a GF Score™ of 83/100 and a GF Value™ of €9.91 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 81.17% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.95 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Alibaba Health Information Technology's Beneish M-Score or its related term are showing as below:

FRA:TWYA' s Beneish M-Score Range Over the Past 10 Years
Min: -2.55   Med: -1.99   Max: 3.93
Current: -1.95

During the past 13 years, the highest Beneish M-Score of Alibaba Health Information Technology was 3.93. The lowest was -2.55. And the median was -1.99.


Alibaba Health Information Technology Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology Beneish M-Score Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 -2.55 -2.03 -2.32 -1.95

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.03 0.00 -2.32 0.00 -1.95

Alibaba Health Information Technology Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Beneish M-Score falls into.


FRA:TWYA
83GF Score
Alibaba Health Information Technology Ltd FRA:TWYA
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Alibaba Health Information Technology for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3163+0.528 * 1.0134+0.404 * 0.7874+0.892 * 1.1012+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9527+4.679 * 0.030292-0.327 * 0.9856
=-2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €383 Mil.
Revenue was €4,299 Mil.
Gross Profit was €1,030 Mil.
Total Current Assets was €1,936 Mil.
Total Assets was €2,898 Mil.
Property, Plant and Equipment(Net PPE) was €11 Mil.
Depreciation, Depletion and Amortization(DDA) was €0 Mil.
Selling, General, & Admin. Expense(SGA) was €355 Mil.
Total Current Liabilities was €639 Mil.
Long-Term Debt & Capital Lease Obligation was €4 Mil.
Net Income was €243 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €155 Mil.
Total Receivables was €265 Mil.
Revenue was €3,904 Mil.
Gross Profit was €948 Mil.
Total Current Assets was €1,566 Mil.
Total Assets was €2,702 Mil.
Property, Plant and Equipment(Net PPE) was €9 Mil.
Depreciation, Depletion and Amortization(DDA) was €7 Mil.
Selling, General, & Admin. Expense(SGA) was €338 Mil.
Total Current Liabilities was €605 Mil.
Long-Term Debt & Capital Lease Obligation was €3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(383.471 / 4299.224) / (264.561 / 3904.297)
=0.089195 / 0.067761
=1.3163

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(948.324 / 3904.297) / (1030.419 / 4299.224)
=0.242892 / 0.239676
=1.0134

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1935.589 + 10.997) / 2898.324) / (1 - (1566.422 + 8.896) / 2702.335)
=0.328375 / 0.417053
=0.7874

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4299.224 / 3904.297
=1.1012

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.35 / (7.35 + 8.896)) / (0 / (0 + 10.997))
=0.452419 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(354.6 / 4299.224) / (338.004 / 3904.297)
=0.08248 / 0.086572
=0.9527

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.787 + 639.237) / 2898.324) / ((3.182 + 605.094) / 2702.335)
=0.221861 / 0.225093
=0.9856

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(243 - 0 - 155.205) / 2898.324
=0.030292

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Alibaba Health Information Technology has a M-score of -2.02 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.95 mean?
Alibaba Health Information Technology (FRA:TWYA) has a Beneish M-Score of -1.95 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Alibaba Health Information Technology and its competitors. According to the industry distribution chart, Alibaba Health Information Technology ranks #513 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 81.2%.
Is Alibaba Health Information Technology's Beneish M-Score too high?
Alibaba Health Information Technology's current Beneish M-Score is -1.95. Based on the distribution chart, Alibaba Health Information Technology ranks #513 out of 632 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #513 out of 632 companies for Beneish M-Score. This places Alibaba Health Information Technology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Alibaba Health Information Technology and its competitors. Alibaba Health Information Technology's current Beneish M-Score is -1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (FRA:TWYA) is currently considered Significantly Undervalued. The stock's GF Value™ is €9.91, compared to a current price of €5.90 — trading 40.5% below its estimated fair value. The current Beneish M-Score is -1.95. Alibaba Health Information Technology's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Alibaba Health Information Technology (FRA:TWYA), the current Beneish M-Score is -1.95 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (FRA:TWYA) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of €5.90 is trading 40.5% below its estimated GF Value™ of €9.91. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for FRA:TWYA:

  • Beneish M-Score: -1.95
  • GF Value™: €9.91 vs. price of €5.90 (40.5% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the FRA:TWYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
83GF Score

Get the complete analysis for FRA:TWYA

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.90
Price
€9.91
GF Value